Clinical Trials update for February 2011

Bayer initiates a randomized Phase III trial of Regorafenib in GIST: On January 10, 2011 Bayer Healthcare in Berlin, Germany announced the initiation of a randomized phase III trial of Regorafenib (BAY 73-4506) for Gastrointestinal Stromal Tumor patients.

By |2019-12-26T14:26:51-05:00February 1st, 2011|Clinical Trials, News, Stivarga|

LRG responds to recent Cancer Cell coverage

Yesterday, there were a series of news stories reporting on an article published by Cooke et al inCancer Cell. Unfortunately, the coverage gave misleading information which could suggest that patients should not take Gleevec (imatinib) or Sutent (sunitinib).

By |2014-09-17T10:15:35-04:00January 19th, 2011|News|

Rita Patient – In Memoriam

A beautiful spirit & consummate caregiver, Rita Catherine Joyce Patient touched the lives of all she knew. Proud wife, mother & grandmother, she passionately supported her family in all of their endeavors. She enjoyed & treasured the blessings of many lifelong friends in Minnesota & Texas & her travels to points beyond.

By |2012-10-02T13:12:36-04:00November 29th, 2009|In Memoriam|
Go to Top